Assyro AI

FDA Orange Book · active-ingredient family

Malathion

Malathion is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:OVIDE · NDA 018613

1

Brand (NDA)

2

Generics (ANDA)

2

Listed patents

0

Exclusivity periods

Brand (NDA) products · lotion

ProductApplicantApplicationTEApproved
OVIDERLDTARONDA 018613—Aug 02, 1982

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
MALATHIONSUVEN PHARMSANDA 091559—May 23, 2012
MALATHIONPHARMOBEDIENTANDA 078743—Mar 06, 2009

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7977324Aug 14, 2026in 2 mo
Product
7560445Feb 01, 2027in 8 mo
SubstanceProductU-986

Malathion — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo